Table 1 |
||||
|
Clinical characteristics. |
||||
|
Entire cohort (n = 24) |
Rest group (n = 7) |
No Rest Group (n = 17) |
Between-group p value |
|
|
|
||||
|
Age (years) |
63 ± 13 (38 – 86) |
68 ± 15 (38 – 86) |
61 ± 12 (41 – 83) |
0.26 |
|
Gender (M/F) |
17/7 |
14/3 |
4/3 |
0.4 |
|
Time post stroke (months) |
38 ± 26 (12 – 121) |
43 ± 38 (12 – 121) |
37 ± 21 (16 – 92) |
0.6 |
|
Stroke type (infarct/hemorrhage/unknown) |
14/8/2 |
5/2/0 |
9/6/2 |
0.6 |
|
Body side affected (left/right/bilateral) |
11/12/1 |
4/3/0 |
7/9/1 |
0.7 |
|
CMSA leg |
5 ± 1 (2 – 7) |
5 ± 1 (2 – 6) |
5 ± 1 (3 – 7) |
0.8 |
|
NIH |
4 ± 2 (0 – 9) |
4 ± 1 (3 – 7) |
/4 ± 2 (0 – 9) |
0.6 |
|
Gait aid (aid/no aid) |
13/11 |
5/2 |
8/9 |
0.3 |
|
VO2peak (ml/kg-min) |
14.9 ± 4.6 (8.0 – 24.5) |
12.5 ± 5.3 (8 – 22.5) |
16.1 ± 4.0 (27.8 – 129.7) |
0.1 |
|
HRpeak (beats/min) |
113.3 ± 4.5 (80.0 – 148.0) |
115.9 ± 5.8 (80.0 – 148.0) |
108.0 ± 7.1 (90.0 – 142.0) |
0.4 |
|
Preferred gait speed (cm/s) |
76.2 ± 29.2 (27.8 – 129.7) |
77.5 ± 25.0 (29.2 – 96.6) |
75.7 ± 31.6 (0.85 – 2.46) |
0.9 |
|
Preferred gait symmetry ratio |
1.44 ± 0.58 (0.85 – 2.9) |
1.58 ± 0.76 (14 – 52) |
1.38 ± 0.5 (39–56) |
0.5 |
|
Berg Balance Scale |
46.7 ± 11.5 (14 – 56) |
37.6 ± 15.7 (14 – 52) |
51.3 ± 4.6 (39 – 56) |
0.006 |
|
Total 6MWT distance (m) |
283.3 ± 136.8 (55 – 552) |
205.7 ± 111.3 (55 – 327) |
315.2 ± 136.1 (108 – 552) |
0.07 |
|
HR at end of 6MWT (beats/min) |
96.3 ± 20.3 (70 – 151) |
98 ± 20 (80 – 134) |
95.5 ± 21.2 (70 – 151) |
0.8 |
|
HR at end of 6MWT (% of HRpeak) |
86.8 ± 3.9 (42 – 115) |
84.1 ± 4.7 (49 – 114) |
92.1 ± 7.2 (67 – 115) |
0.3 |
|
RPE at end of 6MWT |
4 ± 2 (1 – 10) |
5 ± 1 (3 – 10) |
3 ± 1 (1 – 5) |
0.04 |
|
|
||||
|
Sibley et al. Journal of NeuroEngineering and Rehabilitation 2009 6:27 doi:10.1186/1743-0003-6-27 |
||||
